Epithelial-Mesenchymal Transition gene database (dbEMT) Home
dbEMT
dbEMT 2.0
General information | Literature | Expression | lncRNA |Regulation | Mutation | Homolog | Interaction

Basic Information

From Entrez database: 929

Gene ID

929

Name

CD14

Synonym

-;CD14 molecule;CD14;CD14 molecule

Definition

monocyte differentiation antigen CD14|myeloid cell-specific leucine-rich glycoprotein

Position

5q31.1

Gene Type

protein-coding

Pathways and Diseases

From KEGG database

Pathway

Pathogenic Escherichia coli infection;KEGG PATHWAY;hsa05130

Pathway

Amoebiasis;KEGG PATHWAY;hsa05146

Pathway

inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages;PID BioCarta;100152

Pathway

Toll-like receptor signaling pathway;KEGG PATHWAY;hsa04620

Pathway

Regulation of actin cytoskeleton;KEGG PATHWAY;hsa04810

Pathway

LPS transferred from LBP carrier to CD14;PID Reactome;500463

Pathway

MAPK signaling pathway;KEGG PATHWAY;hsa04010

Pathway

Signaling in Immune system;Reactome;REACT:6900

Pathway

toll-like receptor pathway;PID BioCarta;100013

Pathway

Hematopoietic cell lineage;KEGG PATHWAY;hsa04640

Pathway

Endogenous TLR signaling;PID Curated;200177

Pathway

Toll receptor signaling pathway;PANTHER;P00054

Pathway

Phagosome;KEGG PATHWAY;hsa04145

Pathway

Toll Like Receptor 4 (TLR4) Cascade;PID Reactome;500462

Disease

atopy;GAD

Disease

inflammatory bowel disease;GAD

Disease

Atrophy;GAD

Disease

liver disease, alcoholic;GAD

Disease

Intermediate coronary syndrome;FunDO

Disease

Chlamydia;GAD

Disease

IMMUNE;GAD

Disease

Parkinson's disease;GAD

Disease

toxoplasmosis;GAD

Disease

carotid artery damage;GAD

Disease

INFECTION;GAD

Disease

kawasaki disease;GAD

Disease

Stroke;GAD

Disease

Thromboangiitis obliterans;FunDO

Disease

lipoprotein;GAD

Disease

premature rupture of membranes;GAD

Disease

IgE. SPT;GAD

Disease

Enteritis;FunDO

Disease

C-reactive protein;GAD

Disease

cholestasis;GAD

Disease

myocardial infarct;GAD

Disease

allergy dermatitis and eczema;GAD

Disease

Atherosclerosis;FunDO

Disease

Alcoholic liver disease;FunDO

Disease

development of coronary artery lesions;GAD

Disease

Stomach Neoplasms;GAD

Disease

Crohn's disease;GAD

Disease

sepsis;GAD

Disease

sarcoidosis;GAD

Disease

Ulcerative colitis;FunDO

Disease

rhinitis;GAD

Disease

Communicable disease;FunDO

Disease

Dermatitis;FunDO

Disease

systemic inflammatory response syndrome;GAD

Disease

atherosclerosis, coronary;GAD

Disease

cardiovascular disease;GAD

Disease

Systemic infection;FunDO

Disease

Total IgE;GAD

Disease

atherosclerosis, generalized cholesterol, HDL triglycerides;GAD

Disease

Bronchial disease;FunDO

Disease

Drug abuse;FunDO

Disease

IgE response IgG;GAD

Disease

allergic disease;GAD

Disease

burn injury;GAD

Disease

Atherosclerosis;GAD

Disease

Helicobacter Infections;GAD

Disease

atherosclerosis, generalized;GAD

Disease

acute pancreatitis;GAD

Disease

CANCER;GAD

Disease

Amyloidosis;FunDO

Disease

Otitis Media;GAD

Disease

Allergies and autoimmune diseases;KEGG DISEASE

Disease

Gastritis;GAD

Disease

ulcerative colitis;GAD

Disease

Arthritis;FunDO

Disease

IgE;GAD

Disease

nonatopic asthma and food allergy;GAD

Disease

dermatitis and eczema;GAD

Disease

Acute Coronary Syndrome;GAD

Disease

alcoholic liver disease;GAD

Disease

METABOLIC;GAD

Disease

colorectal cancer;GAD

Disease

Capillaries disease;FunDO

Disease

Asthma;KEGG DISEASE;H00079

Disease

CARDIOVASCULAR;GAD

Disease

expired myocardial infarction;GAD

Disease

Alimentary system disease;FunDO

Disease

Biliary Atresia;FunDO

Disease

REPRODUCTION;GAD

Disease

periodontal disease;GAD

Disease

pulmonary function;GAD

Disease

Immune system diseases;KEGG DISEASE

Disease

CD14 expression;GAD

Disease

kidney transplant complications;GAD

Disease

SPT;GAD

Disease

stomach cancer;GAD

Disease

IgE levels;GAD

Disease

Periodontitis;FunDO

Disease

carotid atherosclerosis;GAD

Disease

Hepatitis C;FunDO

Disease

glomerulonephritis;GAD

Disease

Rheumatoid arthritis;FunDO

Disease

nephropathy;GAD

Disease

acute myocardial infarction;GAD

Disease

Asthma;GAD

Disease

Heart Failure;GAD

Disease

periodontitis;GAD

Disease

Stroke;FunDO

Disease

Septic shock;GAD

Disease

CHEMDEPENDENCY;GAD

Disease

respiratory syncytial virus;GAD

Disease

Multiple sclerosis;FunDO

Disease

Familial Mediterranean fever;FunDO

Disease

Myocardial Infarction;GAD

Disease

biliary atresia;GAD

Disease

NEUROLOGICAL;GAD

Disease

Chlamydia pneumoniae infection;GAD

Disease

body mass diabetes, type 2 triglycerides;GAD

Disease

RENAL;GAD

External Links

Links to Entrez Gene

929

Links to all GeneRIF Items

929

Sequence Information

Nucleotide Sequence

>929 : length: 1661
AATTCTACCCCCCTTGGTGCCAACAGATGAGGTTCACAATCTCTTCCACAAAACATGCAG
TTAAATATCTGAGGATATTCAGGGACTTGGATTTGGTGGCAGGAGATCAACATAAACCAA
GACAAGGAAGAAGTCAAAGAAATGAATCAAGTAGATTCTCTGGGATATAAGGAAAGGAAG
GGGGCTGGCTCGGAGGAAGAGAGGTGGGGAGGTGATCAGGGTTCACAGAGGAGGGAACTG
AATGACATCCCAGGATTACATAAACTGTCAGAGGCAGCCGAAGAGTTCACAAGTGTGAAG
CCTGGAAGCCGGCGGGTGCCGCTGTGTAGGAAAGAAGCTAAAGCACTTCCAGAGCCTGTC
CGGAGCTCAGAGGTTCGGAAGACTTATCGACCATGGAGCGCGCGTCCTGCTTGTTGCTGC
TGCTGCTGCCGCTGGTGCACGTCTCTGCGACCACGCCAGAACCTTGTGAGCTGGACGATG
AAGATTTCCGCTGCGTCTGCAACTTCTCCGAACCTCAGCCCGACTGGTCCGAAGCCTTCC
AGTGTGTGTCTGCAGTAGAGGTGGAGATCCATGCCGGCGGTCTCAACCTAGAGCCGTTTC
TAAAGCGCGTCGATGCGGACGCCGACCCGCGGCAGTATGCTGACACGGTCAAGGCTCTCC
GCGTGCGGCGGCTCACAGTGGGAGCCGCACAGGTTCCTGCTCAGCTACTGGTAGGCGCCC
TGCGTGTGCTAGCGTACTCCCGCCTCAAGGAACTGACGCTCGAGGACCTAAAGATAACCG
GCACCATGCCTCCGCTGCCTCTGGAAGCCACAGGACTTGCACTTTCCAGCTTGCGCCTAC
GCAACGTGTCGTGGGCGACAGGGCGTTCTTGGCTCGCCGAGCTGCAGCAGTGGCTCAAGC
CAGGCCTCAAGGTACTGAGCATTGCCCAAGCACACTCGCCTGCCTTTTCCTGCGAACAGG
TTCGCGCCTTCCCGGCCCTTACCAGCCTAGACCTGTCTGACAATCCTGGACTGGGCGAAC
GCGGACTGATGGCGGCTCTCTGTCCCCACAAGTTCCCGGCCATCCAGAATCTAGCGCTGC
GCAACACAGGAATGGAGACGCCCACAGGCGTGTGCGCCGCACTGGCGGCGGCAGGTGTGC
AGCCCCACAGCCTAGACCTCAGCCACAACTCGCTGCGCGCCACCGTAAACCCTAGCGCTC
CGAGATGCATGTGGTCCAGCGCCCTGAACTCCCTCAATCTGTCGTTCGCTGGGCTGGAAC
AGGTGCCTAAAGGACTGCCAGCCAAGCTCAGAGTGCTCGATCTCAGCTGCAACAGACTGA
ACAGGGCGCCGCAGCCTGACGAGCTGCCCGAGGTGGATAACCTGACACTGGACGGGAATC
CCTTCCTGGTCCCTGGAACTGCCCTCCCCCACGAGGGCTCAATGAACTCCGGCGTGGTCC
CAGCCTGTGCACGTTCGACCCTGTCGGTGGGGGTGTCGGGAACCCTGGTGCTGCTCCAAG
GGGCCCGGGGCTTTGCCTAAGATCCAAGACAGAATAATGAATGGACTCAAACTGCCTTGG
CTTCAGGGGAGTCCCGTCAGGACGTTGAGGACTTTTCGACCAATTCAACCCTTTGCCCCA
CCTTTATTAAAATCTTAAACAACGGGTCAAAAAAAAAAAAA



')